iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Trading Up 0% – Here’s Why

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)’s share price were up 0% during trading on Friday . The company traded as high as $25.40 and last traded at $25.38. 21,424 shares were traded during trading, a decline of 34% from the average daily volume of 32,320 shares. The stock had previously closed at $25.37.

iShares Genomics Immunology and Healthcare ETF Trading Up 0.0 %

The company has a market cap of $148.47 million, a price-to-earnings ratio of 2.29 and a beta of 1.14. The company’s 50 day moving average price is $24.50 and its 200 day moving average price is $24.13.

Institutional Investors Weigh In On iShares Genomics Immunology and Healthcare ETF

A hedge fund recently bought a new stake in iShares Genomics Immunology and Healthcare ETF stock. Avior Wealth Management LLC purchased a new stake in iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 9,500 shares of the company’s stock, valued at approximately $234,000. Avior Wealth Management LLC owned 0.16% of iShares Genomics Immunology and Healthcare ETF at the end of the most recent reporting period.

iShares Genomics Immunology and Healthcare ETF Company Profile

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.